These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4135034)

  • 1. Androgen assimilation by normal and hyperplastic dog prostate glands.
    Mawhinney MG; Schwartz FL; Thomas JA; Lloyd JW
    Invest Urol; 1974 Jul; 12(1):17-22. PubMed ID: 4135034
    [No Abstract]   [Full Text] [Related]  

  • 2. Androgens and estrogens in the plasma and prostatic tissue of normal dogs and dogs with benign prostatic hypertrophy.
    Lloyd JW; Thomas JA; Mawhinney MG
    Invest Urol; 1975 Nov; 13(3):220-22. PubMed ID: 53217
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Metabolism of 3H-testosteron and 3H-5alpha-DHT in the normal and adenomatous prostate (author's transl)].
    Becker H; Klosterhalfen H; Voigt KD
    Urol Int; 1973; 28(3):350-5. PubMed ID: 4127746
    [No Abstract]   [Full Text] [Related]  

  • 4. Concentration of dihydrotestosterone and 3 alpha-androstanediol in naturally occurring and androgen-induced prostatic hyperplasia in the dog.
    Moore RJ; Gazak JM; Quebbeman JF; Wilson JD
    J Clin Invest; 1979 Oct; 64(4):1003-10. PubMed ID: 90055
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Testosterone metabolism in benign prostatic hypertrophy. Suppression by diethylstilbestrol and gestonorone capronate.
    Orestano F; Klose K; Rubin A; Knapstein P; Altwein JE
    Invest Urol; 1974 Sep; 12(2):151-6. PubMed ID: 4137236
    [No Abstract]   [Full Text] [Related]  

  • 6. [Pathogenesis of prostatic hyperplasia in normal and adenomatous glands of men and dogs: 3-alpha reduction of dihydrotestesterone].
    Jacob GH
    Endokrinologie; 1977 Oct; 70(2):158-68. PubMed ID: 73458
    [No Abstract]   [Full Text] [Related]  

  • 7. [Androgen, progestin and estrogen receptors in the normal human prostate and in pathology].
    Gerasimova TsI; Smirnov AN; Rozen VB; Buniatian AF; Bol'shakova TD
    Sov Med; 1984; (6):32-6. PubMed ID: 6205454
    [No Abstract]   [Full Text] [Related]  

  • 8. Conversion of 3H-testosterone to dihydrotestosterone in human hypertrophic prostatic tissue.
    Baranowska B; Zgliczyński S
    Nuklearmedizin; 1979; 18(6):297-9. PubMed ID: 94161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Androgen- and estrogen-receptor content in spontaneous and experimentally induced canine prostatic hyperplasia.
    Trachtenberg J; Hicks LL; Walsh PC
    J Clin Invest; 1980 May; 65(5):1051-9. PubMed ID: 6154062
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Androgen dynamics in vitro in the normal and hyperplastic human prostate gland.
    Giorgi EP; Stewart JC; Grant JK; Scott R
    Biochem J; 1971 Jun; 123(1):41-55. PubMed ID: 4108500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrotestosterone in prostatic hypertrophy. II. The formation and content of dihydrotestosterone in the hypertrophic canine prostate and the effect of dihydrotestosterone on prostate growth in the dog.
    Gloyna RE; Siiteri PK; Wilson JD
    J Clin Invest; 1970 Sep; 49(9):1746-53. PubMed ID: 4194769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Is the prostatic adenoma of hormonal origin].
    Bercovici JP; Morfin R; Charles JF
    Nouv Presse Med; 1975 Feb; 4(7):475-8. PubMed ID: 48234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.
    Moore RJ; Gazak JM; Wilson JD
    J Clin Invest; 1979 Mar; 63(3):351-7. PubMed ID: 219036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of histological compositions and apoptosis in canine spontaneous benign prostatic hyperplasia treated with androgen suppressive agents chlormadinone acetate and finasteride.
    Shibata Y; Fukabori Y; Ito K; Suzuki K; Yamanaka H
    J Urol; 2001 Jan; 165(1):289-93. PubMed ID: 11125427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Uptake of radiolabeled testosterone, 5-alpha-dihydrotestosterone, estradiol, and pregnenolone by canine prostate.
    Sturman MF; Beierwaltes WH; Prakash S; Ryo UY; Ice RD; Gitomer W
    J Nucl Med; 1974 Feb; 15(2):94-7. PubMed ID: 4810596
    [No Abstract]   [Full Text] [Related]  

  • 16. Correlated biochemical and stereological studies on testosterone metabolism in the stromal and epithelial compartment of human benign prostatic hyperplasia.
    Schweikert HU; Totzauer P; Rohr HP; Bartsch G
    J Urol; 1985 Aug; 134(2):403-7. PubMed ID: 2410636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Benign prostatic hyperplasia: etiological considerations.
    Walsh PC
    Prog Clin Biol Res; 1976; 6():1-8. PubMed ID: 66685
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some aspects of the pathogenesis of prostatic hyperplasia.
    Tveter KJ
    Acta Pathol Microbiol Scand Suppl; 1974; Suppl 248():167-74. PubMed ID: 4141576
    [No Abstract]   [Full Text] [Related]  

  • 19. Testosterone metabolism in cultured hyperplasia of the human prostate.
    McMahon MJ; Butler AV; Thomas GH
    Acta Endocrinol (Copenh); 1974 Dec; 77(4):784-93. PubMed ID: 4139859
    [No Abstract]   [Full Text] [Related]  

  • 20. Expression of androgen, oestrogen alpha and beta, and progesterone receptors in the canine prostate: differences between normal, inflamed, hyperplastic and neoplastic glands.
    Gallardo F; Mogas T; Baró T; Rabanal R; Morote J; Abal M; Reventós J; Lloreta J
    J Comp Pathol; 2007 Jan; 136(1):1-8. PubMed ID: 17078963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.